| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.39 | 1e-26 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.37 | 5e-24 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.32 | 4e-21 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.38 | 2e-16 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-12 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-11 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |